STAT+: GSK touts lung cancer data from two drugs

Late-stage results for Definium’s LSD treatment, AstraZeneca breast cancer drug fails key trial, and more biotech news from The Readout Leon Neal/Getty Images Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Definium’s LSD therapy has a strong performacne in a pivotal anxiety trial, drugmaker deals could gut “most-favored nation” Medicare savings, and more. In this endless heat wave my house is now overrun with flies and I think I give up and will also become a fly. They win. STAT+ Exclusive Story Already have an account? Log in This article is exclusive to STAT+ subscribers Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts. Already have an account? Log in View All Plans To read the rest of this story subscribe to STAT+. Subscribe Meghana Keshavan covers biotech and contributes to The Readout newsletter.